Cargando…
Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
Parasitic infections contribute significantly to worldwide morbidity and mortality. Antibiotic treatment is essential for managing patients infected with these parasites since control is otherwise challenging and there are no vaccines available for prevention. However, new antimicrobial therapies ar...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991622/ https://www.ncbi.nlm.nih.gov/pubmed/33777846 http://dx.doi.org/10.3389/fcimb.2021.633194 |
_version_ | 1783669210572914688 |
---|---|
author | Shirley, Debbie-Ann Sharma, Ishrya Warren, Cirle A. Moonah, Shannon |
author_facet | Shirley, Debbie-Ann Sharma, Ishrya Warren, Cirle A. Moonah, Shannon |
author_sort | Shirley, Debbie-Ann |
collection | PubMed |
description | Parasitic infections contribute significantly to worldwide morbidity and mortality. Antibiotic treatment is essential for managing patients infected with these parasites since control is otherwise challenging and there are no vaccines available for prevention. However, new antimicrobial therapies are urgently needed as significant problems exist with current treatments such as drug resistance, limited options, poor efficacy, as well as toxicity. This situation is made worse by the challenges of drug discovery and development which is costly especially for non-profitable infectious diseases, time-consuming, and risky with a high failure rate. Drug repurposing which involves finding new use for existing drugs may help to more rapidly identify therapeutic candidates while drastically cutting costs of drug research and development. In this perspective article, we discuss the importance of drug repurposing, review disulfiram pharmacology, and highlight emerging data that supports repurposing disulfiram as an anti-parasitic, exemplified by the major diarrhea-causing parasite Entamoeba histolytica. |
format | Online Article Text |
id | pubmed-7991622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79916222021-03-26 Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent Shirley, Debbie-Ann Sharma, Ishrya Warren, Cirle A. Moonah, Shannon Front Cell Infect Microbiol Cellular and Infection Microbiology Parasitic infections contribute significantly to worldwide morbidity and mortality. Antibiotic treatment is essential for managing patients infected with these parasites since control is otherwise challenging and there are no vaccines available for prevention. However, new antimicrobial therapies are urgently needed as significant problems exist with current treatments such as drug resistance, limited options, poor efficacy, as well as toxicity. This situation is made worse by the challenges of drug discovery and development which is costly especially for non-profitable infectious diseases, time-consuming, and risky with a high failure rate. Drug repurposing which involves finding new use for existing drugs may help to more rapidly identify therapeutic candidates while drastically cutting costs of drug research and development. In this perspective article, we discuss the importance of drug repurposing, review disulfiram pharmacology, and highlight emerging data that supports repurposing disulfiram as an anti-parasitic, exemplified by the major diarrhea-causing parasite Entamoeba histolytica. Frontiers Media S.A. 2021-03-11 /pmc/articles/PMC7991622/ /pubmed/33777846 http://dx.doi.org/10.3389/fcimb.2021.633194 Text en Copyright © 2021 Shirley, Sharma, Warren and Moonah http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Shirley, Debbie-Ann Sharma, Ishrya Warren, Cirle A. Moonah, Shannon Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent |
title | Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent |
title_full | Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent |
title_fullStr | Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent |
title_full_unstemmed | Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent |
title_short | Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent |
title_sort | drug repurposing of the alcohol abuse medication disulfiram as an anti-parasitic agent |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991622/ https://www.ncbi.nlm.nih.gov/pubmed/33777846 http://dx.doi.org/10.3389/fcimb.2021.633194 |
work_keys_str_mv | AT shirleydebbieann drugrepurposingofthealcoholabusemedicationdisulfiramasanantiparasiticagent AT sharmaishrya drugrepurposingofthealcoholabusemedicationdisulfiramasanantiparasiticagent AT warrencirlea drugrepurposingofthealcoholabusemedicationdisulfiramasanantiparasiticagent AT moonahshannon drugrepurposingofthealcoholabusemedicationdisulfiramasanantiparasiticagent |